Iovance Biotherapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Iovance Biotherapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update

Iovance Biotherapeutics (IOVA) Misses Q1 EPS by 4c

May 5, 2020 5:27 PM EDT

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q1 EPS of ($0.55), $0.04 worse than the analyst estimate of ($0.51).

We continue making strong progress toward commercializing Iovance TIL for melanoma and cervical cancer indications, said Maria Fardis, Ph.D., MBA, Iovance President and Chief Executive Officer. While COVID-19 has... More